Literature DB >> 16097647

Detection of cerebrospinal fluid leakage in intracranial hypotension with radionuclide cisternography and blood activity monitoring.

Miwako Takahashi1, Toshimitsu Momose, Masashi Kameyama, Shinji Mizuno, Yoshitaka Kumakura, Kuni Ohtomo.   

Abstract

UNLABELLED: Radionuclide cisternography is an indispensable examination to detect cerebrospinal fluid (CSF) leakage in patients suspected of having spontaneous intracranial hypotension (SIH). However, it sometimes fails to demonstrate the site of CSF leakage, and in such cases, early bladder visualization is utilized for the diagnosis of SIH as an indirect finding. The aim of this work is to improve the diagnostic ability of radionuclide cisternography and to reevaluate the reliability of early bladder visualization as an indirect finding of CSF leakage.
METHODS: We obtained serial images during the first hour after injection as well as the following time points in 4 patients with SIH and 5 with normal pressure hydrocephalus (NPH) as a control. We also performed blood sampling over time to measure blood radioactivity concentrations.
RESULTS: All 4 patients with SIH demonstrated leakage, 2 of 4 within one hour after injection. Bladder visualization was observed falsely in 4 of 5 patients with NPH, considered to be the result of a lumbar puncture complication. In this false bladder visualization, blood radioactivity showed a more rapid raise and fall than in CSF leakage of SIH.
CONCLUSIONS: The combination of radionuclide cisternography, including early time points and blood sampling, may enable accurate diagnosis of SIH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097647     DOI: 10.1007/bf02984630

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  1 in total

1.  The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography.

Authors:  Francesco Cicone; Carolina Del Mastro; Francesco Scopinaro
Journal:  Iran J Radiol       Date:  2014-10-20       Impact factor: 0.212

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.